Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia

Kumiko Hirokoshi, Yohei Maeshima, Kazuko Kobayashi, Eiji Matsuura, Hitoshi Sugiyama, Yasushi Yamasaki, Hisashi Masuyama, Yuji Hiramatsu, Hirofumi Makino

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Numerous recent reports demonstrated that changes in serum levels of angiogenesis-related factors were associated with preeclampsia. Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia. Methods: The levels of serum Ang-2 and Tie-2, a receptor for Ang-1 expressed on endothelial cells, were determined by enzyme-linked immunosorbent assay. Results: The concentrations of serum Ang-2 were significantly elevated in healthy pregnant women (18.9 ng/mL) as compared to nonpregnant women or women in postpartum period. Increase in the levels of serum Ang-2 was significantly suppressed in preeclamptic women (4.5 ng/mL). The serum Ang-2 concentrations inversely correlated with gestational age in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations positively correlated with placental weight or mean blood pressure (BP) in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations inversely correlated with proteinuria in preeclamptic women. The serum concentrations of Tie-2 were not significantly different between preeclamptic and nonpreeclamptic women. Conclusions: These results suggest the potential requirement of circulating Ang-2 in proper formation of placental vasculatures during pregnancy. Although we cannot exclude the possibility that suppression in the increase of serum Ang-2 levels during pregnancy in preeclampsia as a consequence rather than a cause, measurement of serum Ang-2 concentration in pregnant women may serve as a useful marker in the diagnosis and potentially in predicting subsequent development of preeclampsia.

Original languageEnglish
Pages (from-to)1181-1188
Number of pages8
JournalAmerican Journal of Hypertension
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Angiopoietin-2
Pre-Eclampsia
Pregnancy
Serum
Pregnant Women
Angiopoietin-1
Angiogenesis Inducing Agents
Proteinuria
Postpartum Period
Vascular Endothelial Growth Factor A
Gestational Age

Keywords

  • Angiogenesis
  • Angiopoietin-2
  • Preeclampsia
  • Proteinuria
  • Tie-2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. / Hirokoshi, Kumiko; Maeshima, Yohei; Kobayashi, Kazuko; Matsuura, Eiji; Sugiyama, Hitoshi; Yamasaki, Yasushi; Masuyama, Hisashi; Hiramatsu, Yuji; Makino, Hirofumi.

In: American Journal of Hypertension, Vol. 18, No. 9, 09.2005, p. 1181-1188.

Research output: Contribution to journalArticle

@article{8c6aa96af75f4872a793b4e20e953726,
title = "Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia",
abstract = "Background: Numerous recent reports demonstrated that changes in serum levels of angiogenesis-related factors were associated with preeclampsia. Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia. Methods: The levels of serum Ang-2 and Tie-2, a receptor for Ang-1 expressed on endothelial cells, were determined by enzyme-linked immunosorbent assay. Results: The concentrations of serum Ang-2 were significantly elevated in healthy pregnant women (18.9 ng/mL) as compared to nonpregnant women or women in postpartum period. Increase in the levels of serum Ang-2 was significantly suppressed in preeclamptic women (4.5 ng/mL). The serum Ang-2 concentrations inversely correlated with gestational age in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations positively correlated with placental weight or mean blood pressure (BP) in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations inversely correlated with proteinuria in preeclamptic women. The serum concentrations of Tie-2 were not significantly different between preeclamptic and nonpreeclamptic women. Conclusions: These results suggest the potential requirement of circulating Ang-2 in proper formation of placental vasculatures during pregnancy. Although we cannot exclude the possibility that suppression in the increase of serum Ang-2 levels during pregnancy in preeclampsia as a consequence rather than a cause, measurement of serum Ang-2 concentration in pregnant women may serve as a useful marker in the diagnosis and potentially in predicting subsequent development of preeclampsia.",
keywords = "Angiogenesis, Angiopoietin-2, Preeclampsia, Proteinuria, Tie-2",
author = "Kumiko Hirokoshi and Yohei Maeshima and Kazuko Kobayashi and Eiji Matsuura and Hitoshi Sugiyama and Yasushi Yamasaki and Hisashi Masuyama and Yuji Hiramatsu and Hirofumi Makino",
year = "2005",
month = "9",
doi = "10.1016/j.amjhyper.2005.03.745",
language = "English",
volume = "18",
pages = "1181--1188",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia

AU - Hirokoshi, Kumiko

AU - Maeshima, Yohei

AU - Kobayashi, Kazuko

AU - Matsuura, Eiji

AU - Sugiyama, Hitoshi

AU - Yamasaki, Yasushi

AU - Masuyama, Hisashi

AU - Hiramatsu, Yuji

AU - Makino, Hirofumi

PY - 2005/9

Y1 - 2005/9

N2 - Background: Numerous recent reports demonstrated that changes in serum levels of angiogenesis-related factors were associated with preeclampsia. Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia. Methods: The levels of serum Ang-2 and Tie-2, a receptor for Ang-1 expressed on endothelial cells, were determined by enzyme-linked immunosorbent assay. Results: The concentrations of serum Ang-2 were significantly elevated in healthy pregnant women (18.9 ng/mL) as compared to nonpregnant women or women in postpartum period. Increase in the levels of serum Ang-2 was significantly suppressed in preeclamptic women (4.5 ng/mL). The serum Ang-2 concentrations inversely correlated with gestational age in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations positively correlated with placental weight or mean blood pressure (BP) in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations inversely correlated with proteinuria in preeclamptic women. The serum concentrations of Tie-2 were not significantly different between preeclamptic and nonpreeclamptic women. Conclusions: These results suggest the potential requirement of circulating Ang-2 in proper formation of placental vasculatures during pregnancy. Although we cannot exclude the possibility that suppression in the increase of serum Ang-2 levels during pregnancy in preeclampsia as a consequence rather than a cause, measurement of serum Ang-2 concentration in pregnant women may serve as a useful marker in the diagnosis and potentially in predicting subsequent development of preeclampsia.

AB - Background: Numerous recent reports demonstrated that changes in serum levels of angiogenesis-related factors were associated with preeclampsia. Here, we determined the serum concentration of angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of angiogenic stimuli such as vascular endothelial growth factor (VEGF), in women with preeclampsia. Methods: The levels of serum Ang-2 and Tie-2, a receptor for Ang-1 expressed on endothelial cells, were determined by enzyme-linked immunosorbent assay. Results: The concentrations of serum Ang-2 were significantly elevated in healthy pregnant women (18.9 ng/mL) as compared to nonpregnant women or women in postpartum period. Increase in the levels of serum Ang-2 was significantly suppressed in preeclamptic women (4.5 ng/mL). The serum Ang-2 concentrations inversely correlated with gestational age in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations positively correlated with placental weight or mean blood pressure (BP) in healthy pregnant women, but not in preeclamptic women. The serum Ang-2 concentrations inversely correlated with proteinuria in preeclamptic women. The serum concentrations of Tie-2 were not significantly different between preeclamptic and nonpreeclamptic women. Conclusions: These results suggest the potential requirement of circulating Ang-2 in proper formation of placental vasculatures during pregnancy. Although we cannot exclude the possibility that suppression in the increase of serum Ang-2 levels during pregnancy in preeclampsia as a consequence rather than a cause, measurement of serum Ang-2 concentration in pregnant women may serve as a useful marker in the diagnosis and potentially in predicting subsequent development of preeclampsia.

KW - Angiogenesis

KW - Angiopoietin-2

KW - Preeclampsia

KW - Proteinuria

KW - Tie-2

UR - http://www.scopus.com/inward/record.url?scp=25144443013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144443013&partnerID=8YFLogxK

U2 - 10.1016/j.amjhyper.2005.03.745

DO - 10.1016/j.amjhyper.2005.03.745

M3 - Article

VL - 18

SP - 1181

EP - 1188

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 9

ER -